Developmental changes in the rat atriopeptin hormonal system
- PMID: 2952670
- PMCID: PMC424376
- DOI: 10.1172/JCI112957
Developmental changes in the rat atriopeptin hormonal system
Abstract
We undertook a study of fetal synthesis, storage, and release of atriopeptin (AP). Plasma levels of both atriopeptin immunoreactivity (APir) and the NH2-terminal fragment of the prohormone immunoreactivity (NTFir) were very high in the fetus (4 and 20 times the maternal plasma, respectively). However, the atrial content of the AP was low, but surprisingly, ventricular content of AP was quite high (relative to the adult) in the fetus and fell postnatally. Atrial AP messenger RNA (mRNA) increased with postnatal age, whereas ventricular mRNA was extremely high in the fetus and fell rapidly after birth. High fetal plasma peptide levels may derive from the mother since infusion of exogenous atriopeptin 24 into the mother resulted in parallel increases in fetal and maternal peptide levels. Fetal plasma APir and NTFir levels partially reflect the markedly reduced total renal metabolic capacity compared with that of the adult. Plasma levels fell progressively after birth; whereas neonatal atrial content rose substantially. Plasma AP and NTF were simultaneously elevated in both the maternal and fetal circulation after vasopressin injection of the mother. The fetus can also respond to exogenous stimuli (vasopressin or indomethacin--presumably via ductal closure) and promptly release substantial amounts of peptide into its circulation. Thus, it appears that the AP hormonal system is functional during fetal life and responds avidly to increases in intracardiac pressure as does the mature animal.
Similar articles
-
Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.J Pharmacol Exp Ther. 1986 Nov;239(2):474-9. J Pharmacol Exp Ther. 1986. PMID: 2945922
-
Proteolytic processing of atriopeptin prohormone.Mol Pharmacol. 1986 Dec;30(6):552-7. Mol Pharmacol. 1986. PMID: 2946928
-
Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).Toxicol Appl Pharmacol. 1996 Feb;136(2):269-79. doi: 10.1006/taap.1996.0034. Toxicol Appl Pharmacol. 1996. PMID: 8619235
-
[Atrial natriuretic hormone in the human].Z Kardiol. 1987 Nov;76(11):655-70. Z Kardiol. 1987. PMID: 2962372 Review. German.
-
Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development--a review.Placenta. 2002 Apr;23 Suppl A:S9-19. doi: 10.1053/plac.2002.0771. Placenta. 2002. PMID: 11978055 Review.
Cited by
-
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.Adv Drug Deliv Rev. 2016 Jan 15;96:110-34. doi: 10.1016/j.addr.2015.04.019. Epub 2015 May 5. Adv Drug Deliv Rev. 2016. PMID: 25956564 Free PMC article. Review.
-
Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.Br J Pharmacol. 1990 Apr;99(4):701-8. doi: 10.1111/j.1476-5381.1990.tb12992.x. Br J Pharmacol. 1990. PMID: 2141796 Free PMC article.
-
Developmental pattern of cyclic guanosine monophosphate production stimulated by atrial natriuretic peptide in glomeruli microdissected from kidneys of young rats.Pflugers Arch. 1990 Jul;416(5):519-25. doi: 10.1007/BF00382684. Pflugers Arch. 1990. PMID: 2172915
-
Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.Br J Pharmacol. 1991 Feb;102(2):453-61. doi: 10.1111/j.1476-5381.1991.tb12194.x. Br J Pharmacol. 1991. PMID: 1826618 Free PMC article.
-
Expression of the gene for the atrial natriuretic peptide in cardiac myocytes in vitro.Cardiovasc Drugs Ther. 1988 Nov;2(4):479-86. doi: 10.1007/BF00051186. Cardiovasc Drugs Ther. 1988. PMID: 2979001
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources